Pirfenidone is an antifibrotic medication commonly used in the treatment of idiopathic pulmonary fibrosis (IPF). This drug has garnered attention in histology due to its effects on cellular and tissue structures in fibrotic diseases. Pirfenidone inhibits the synthesis of collagen and other proteins involved in the fibrotic process, thereby modulating tissue remodeling.
